One email a month.Extra briefs for major congresses (ESMO, ASCO, WCLC).No spam, just what matters.
Pembrolizumab
+6
Nov 2, 2026
•
5 min read
Highlights from landmark October studies in thoracic oncology.
ADC
Nov 1, 2026
7 min read
The thoracic oncology studies that matter most from ESMO 2026, including major positive and negative randomized trials.
Radiation
+8
Oct 2, 2026
Highlights from landmark September studies in thoracic oncology.